FDA Orders Eli Lilly to Submit Additional Safety Data for Foundayo

Released April 14, FDA approval documents require Eli Lilly to submit further cardiovascular and hepatic safety data on Foundayo (orforglipron). The rapid approval carried the Commissioner's National Priority Voucher.